» Articles » PMID: 28245834

Is Tea Consumption Associated with the Serum Uric Acid Level, Hyperuricemia or the Risk of Gout? A Systematic Review and Meta-analysis

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2017 Mar 2
PMID 28245834
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to examine the associations of tea consumption with the serum uric acid (SUA) level, hyperuricemia (HU) and the risk of gout.

Methods: A comprehensive literature search up to June 2016, using PUBMED and EMBASE databases, was conducted to identify the relevant observational studies that examined the associations of tea consumption with the SUA level, HU and the risk of gout.

Results: A total of fifteen observational studies were included in this study, and nine studies were extracted for meta-analysis. For the SUA level, seven studies were included. According to the combined weighted mean difference (WMD), there was no significant difference between the highest and the lowest tea intake category in terms of the SUA level (WMD = 7.41 μmol/L, 95%CI: -2.34 to 17.15; P = 0.136). In subgroup analysis including three studies, green tea consumption was positively associated with the SUA level (WMD = 17.20 μmol/L, 95%CI: 7.00 to 27.40; P = 0.01). For the prevalence of HU, five studies were included. The overall multi-variable adjusted odds ratio (OR) for the highest versus the lowest category of tea consumption was 0.98 (95%CI: 0.77 to 1.24; P = 0.839). For the risk of gout, two prospective cohort studies showed that there was no relationship between tea consumption and the risk of gout in males and females, respectively.

Conclusion: The current evidences suggest that tea consumption does not seem to be associated with the SUA level, HU and the risk of gout. However, due to the limited number of studies, green tea consumption might be positively associated with the SUA level. More well-designed prospective cohort studies are needed to elaborate these issues further.

Citing Articles

A Bidirectional Mendelian Randomization Study of Tea-Drinking Habits and Risk of Elevated Serum Uric Acid Levels.

Yan W, Wang X, Peng Z, Deng Q, Zhu M, Meng F Int J Rheum Dis. 2025; 28(2):e70128.

PMID: 39953773 PMC: 11829186. DOI: 10.1111/1756-185X.70128.


Phytochemical compounds for treating hyperuricemia associated with gout: a systematic review.

Chenchula S, Ghanta M, Alhammadi M, Mohammed A, Anitha K, Nuthalapati P Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39636406 DOI: 10.1007/s00210-024-03686-4.


Tea consumption, serum uric acid levels and hyperuricemia: a systematic review and meta-analysis.

Zhu W, Wang Q, Xu L, Yang X, Lei Y Clin Rheumatol. 2024; 44(1):67-80.

PMID: 39612018 DOI: 10.1007/s10067-024-07252-4.


Association between Visceral Adiposity Index and Hyperuricemia among Steelworkers: The Moderating Effects of Drinking Tea.

Huang X, Zhong Z, He J, Them S, Chen M, Liu A Nutrients. 2024; 16(18).

PMID: 39339821 PMC: 11435409. DOI: 10.3390/nu16183221.


Distinguishable short-term effects of tea and water drinking on human saliva redox.

Meng X, Chong P, Ke L, Zhang P, Li L, Song B NPJ Sci Food. 2024; 8(1):22.

PMID: 38649360 PMC: 11035607. DOI: 10.1038/s41538-024-00266-x.


References
1.
McAdams-DeMarco M, Maynard J, Baer A, Coresh J . Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich). 2012; 14(10):675-9. PMC: 3464949. DOI: 10.1111/j.1751-7176.2012.00674.x. View

2.
Uaratanawong S, Suraamornkul S, Angkeaw S, Uaratanawong R . Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol. 2011; 30(7):887-93. DOI: 10.1007/s10067-011-1699-0. View

3.
Meki A, Hamed E, Ezam K . Effect of green tea extract and vitamin C on oxidant or antioxidant status of rheumatoid arthritis rat model. Indian J Clin Biochem. 2012; 24(3):280-7. PMC: 3453301. DOI: 10.1007/s12291-009-0053-7. View

4.
Aune D, Norat T, Vatten L . Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr. 2014; 53(8):1591-601. DOI: 10.1007/s00394-014-0766-0. View

5.
Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S . Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res. 2004; 27(4):227-33. DOI: 10.1291/hypres.27.227. View